Addiction-like Synaptic Impairments in Diet-Induced Obesity
Research insights suggest that supporting these pathways may contribute to improved training recovery cycles, enhanced nutrient utilization, and sustained anabolic signaling
Starting July 2026, Wegovy is also one of the three drugs covered under the GLP-1 Bridge program for weight loss at a $50/month copay, manufactured by Novo Nordisk
Saline solutions may affect peptide stability differently than bacteriostatic water
What it is GLP-1 therapy, in a tablet you take by mouth GLP-1 medications are part of the conversation around weight management, and for many people the weekly injection is the one thing that has kept them from starting a clinician-led plan
For women navigating these considerations alongside hormonal changes, our guide on peptides for women over 40 and menopause-specific strategies provides additional context on how body composition changes interact with hormonal shifts
